177 related articles for article (PubMed ID: 25554480)
1. Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue.
Norden DM; Devine R; Bicer S; Jing R; Reiser PJ; Wold LE; Godbout JP; McCarthy DO
Physiol Behav; 2015 Mar; 140():230-5. PubMed ID: 25554480
[TBL] [Abstract][Full Text] [Related]
2. Ibuprofen ameliorates fatigue- and depressive-like behavior in tumor-bearing mice.
Norden DM; McCarthy DO; Bicer S; Devine RD; Reiser PJ; Godbout JP; Wold LE
Life Sci; 2015 Dec; 143():65-70. PubMed ID: 26498217
[TBL] [Abstract][Full Text] [Related]
3. Tumor growth increases neuroinflammation, fatigue and depressive-like behavior prior to alterations in muscle function.
Norden DM; Bicer S; Clark Y; Jing R; Henry CJ; Wold LE; Reiser PJ; Godbout JP; McCarthy DO
Brain Behav Immun; 2015 Jan; 43():76-85. PubMed ID: 25102452
[TBL] [Abstract][Full Text] [Related]
4. Naringenin protects against oxido-inflammatory aberrations and altered tryptophan metabolism in olfactory bulbectomized-mice model of depression.
Bansal Y; Singh R; Saroj P; Sodhi RK; Kuhad A
Toxicol Appl Pharmacol; 2018 Sep; 355():257-268. PubMed ID: 30017640
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide-induced brain activation of the indoleamine 2,3-dioxygenase and depressive-like behavior are impaired in a mouse model of metabolic syndrome.
Dinel AL; André C; Aubert A; Ferreira G; Layé S; Castanon N
Psychoneuroendocrinology; 2014 Feb; 40():48-59. PubMed ID: 24485475
[TBL] [Abstract][Full Text] [Related]
6. Activation of Brain Indoleamine-2,3-dioxygenase Contributes to Depressive-Like Behavior Induced by an Intracerebroventricular Injection of Streptozotocin in Mice.
Souza LC; Jesse CR; de Gomes MG; Del Fabbro L; Goes ATR; Donato F; Boeira SP
Neurochem Res; 2017 Oct; 42(10):2982-2995. PubMed ID: 28631232
[TBL] [Abstract][Full Text] [Related]
7. Comparison of fluoxetine and 1-methyl-L-tryptophan in treatment of depression-like illness in Bacillus Calmette-Guerin-induced inflammatory model of depression in mice.
Rana P; Sharma AK; Jain S; Deshmukh P; Bhattacharya SK; Banerjee BD; Mediratta PK
J Basic Clin Physiol Pharmacol; 2016 Nov; 27(6):569-576. PubMed ID: 27508960
[TBL] [Abstract][Full Text] [Related]
8. Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions.
Vilar-Pereira G; Silva AA; Pereira IR; Silva RR; Moreira OC; de Almeida LR; de Souza AS; Rocha MS; Lannes-Vieira J
Brain Behav Immun; 2012 Oct; 26(7):1136-49. PubMed ID: 22841695
[TBL] [Abstract][Full Text] [Related]
9. Intracerebroventricular Administration of Streptozotocin as an Experimental Approach to Depression: Evidence for the Involvement of Proinflammatory Cytokines and Indoleamine-2,3-Dioxygenase.
Souza LC; Jesse CR; de Gomes MG; Viana CE; Mattos E; Silva NC; Boeira SP
Neurotox Res; 2017 May; 31(4):464-477. PubMed ID: 28155213
[TBL] [Abstract][Full Text] [Related]
10. Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge.
Parrott JM; Redus L; O'Connor JC
J Neuroinflammation; 2016 May; 13(1):124. PubMed ID: 27233247
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation.
Parrott JM; Redus L; Santana-Coelho D; Morales J; Gao X; O'Connor JC
Transl Psychiatry; 2016 Oct; 6(10):e918. PubMed ID: 27754481
[TBL] [Abstract][Full Text] [Related]
12. Allostatic tumor-burden induces depression-associated changes in hepatoma-bearing mice.
Qi H; Ma J; Liu YM; Yang L; Peng L; Wang H; Chen HZ
J Neurooncol; 2009 Sep; 94(3):367-72. PubMed ID: 19381448
[TBL] [Abstract][Full Text] [Related]
13. Danzhi Xiaoyao San ameliorates depressive-like behavior by shifting toward serotonin via the downregulation of hippocampal indoleamine 2,3-dioxygenase.
Zhu X; Jing L; Chen C; Shao M; Fan Q; Diao J; Liu Y; Lv Z; Sun X
J Ethnopharmacol; 2015 Feb; 160():86-93. PubMed ID: 25435286
[TBL] [Abstract][Full Text] [Related]
14. The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression.
Dobos N; de Vries EF; Kema IP; Patas K; Prins M; Nijholt IM; Dierckx RA; Korf J; den Boer JA; Luiten PG; Eisel UL
J Alzheimers Dis; 2012; 28(4):905-15. PubMed ID: 22112548
[TBL] [Abstract][Full Text] [Related]
15. Diet-induced obesity progressively alters cognition, anxiety-like behavior and lipopolysaccharide-induced depressive-like behavior: focus on brain indoleamine 2,3-dioxygenase activation.
André C; Dinel AL; Ferreira G; Layé S; Castanon N
Brain Behav Immun; 2014 Oct; 41():10-21. PubMed ID: 24681251
[TBL] [Abstract][Full Text] [Related]
16. Influence of the brain sexual differentiation process on despair and antidepressant-like effect of fluoxetine in the rat forced swim test.
Gómez ML; Martínez-Mota L; Estrada-Camarena E; Fernández-Guasti A
Neuroscience; 2014 Mar; 261():11-22. PubMed ID: 24374081
[TBL] [Abstract][Full Text] [Related]
17. Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration.
Ohgi Y; Futamura T; Kikuchi T; Hashimoto K
Pharmacol Biochem Behav; 2013 Feb; 103(4):853-9. PubMed ID: 23262300
[TBL] [Abstract][Full Text] [Related]
18. Central administration of murine interferon-α induces depressive-like behavioral, brain cytokine and neurochemical alterations in mice: a mini-review and original experiments.
Hayley S; Scharf J; Anisman H
Brain Behav Immun; 2013 Jul; 31():115-27. PubMed ID: 22884959
[TBL] [Abstract][Full Text] [Related]
19. Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: Relevance to cancer-related fatigue.
Kim S; Miller BJ; Stefanek ME; Miller AH
Cancer; 2015 Jul; 121(13):2129-36. PubMed ID: 25728366
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801.
Farley S; Dumas S; El Mestikawy S; Giros B
Neuropharmacology; 2012 Jan; 62(1):503-17. PubMed ID: 21945287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
